0001125376-21-000078.txt : 20210429 0001125376-21-000078.hdr.sgml : 20210429 20210429161247 ACCESSION NUMBER: 0001125376-21-000078 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20210429 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210429 DATE AS OF CHANGE: 20210429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENSIGN GROUP, INC CENTRAL INDEX KEY: 0001125376 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] IRS NUMBER: 330861263 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33757 FILM NUMBER: 21870709 BUSINESS ADDRESS: STREET 1: 29222 RANCHO VIEJO RD. STREET 2: SUITE 127 CITY: SAN JUAN CAPISTRANO STATE: CA ZIP: 92675 BUSINESS PHONE: (949) 487-9500 MAIL ADDRESS: STREET 1: 29222 RANCHO VIEJO RD. STREET 2: SUITE 127 CITY: SAN JUAN CAPISTRANO STATE: CA ZIP: 92675 FORMER COMPANY: FORMER CONFORMED NAME: ENSIGN GROUP INC DATE OF NAME CHANGE: 20000930 8-K 1 ensg-20210429.htm 8-K ensg-20210429
0001125376false00011253762021-04-292021-04-29


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 29, 2021
The Ensign Group, Inc.
(Exact name of registrant as specified in its charter)
     
Delaware 001-33757 33-0861263
     
(State or other jurisdiction
of incorporation)
 (Commission File Number) (IRS Employer Identification No.)

29222 Rancho Viejo Road, Suite 127, 
San Juan Capistrano,CA92675
   
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (949) 487-9500
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareENSGNasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 2.02. Results of Operations and Financial Condition.
On April 29, 2021 The Ensign Group, Inc. (the Company) issued a press release reporting the financial results of the Company for its first quarter ended March 31, 2021. A copy of the press release is attached to this Current Report as Exhibit 99.1.
The press release includes “non-GAAP financial measures.” Specifically, the press release refers to EBITDA, Adjusted EBITDA, Adjusted EBITDAR and Funds from Operations (FFO) for our real estate segment. EBITDA, Adjusted EBITDA, Adjusted EBITDAR and FFO are supplemental non-GAAP financial measures. Regulation G, Conditions for Use of Non-GAAP Financial Measures, and other provisions of the Securities Exchange Act of 1934, as amended, define and prescribe the conditions for use of certain non-GAAP financial information. EBITDA consists of net income before (a) interest expense, net, (b) provisions for income taxes and (c) depreciation and amortization. Adjusted EBITDA consists of net income before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) stock-based compensation expense; (e) results of operations not at full capacity, excluding depreciation, interest and income taxes, (f) acquisition related costs and (g) gain on sale of assets. Adjusted EBITDAR consists of net income before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) stock-based compensation expense; (f) results of operations not at full capacity, excluding rent, depreciation, interest and income taxes, (g) acquisition related costs and (h) gain on sale of assets. Funds from Operations (FFO) for our real estate segment consists of segment income, excluding gains or losses from sales of real estate, insurance recoveries related to real estate and impairment of depreciable real estate assets and including depreciation and amortization related to real estate to earnings. The company believes that the presentation of EBITDA, adjusted EBITDA, FFO, adjusted net income and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. Adjusted EBITDAR is a financial valuation measure that is not specified in GAAP. This measure is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense. The company believes disclosure of adjusted net income, adjusted net income per share, FFO, EBITDA, adjusted EBITDA and adjusted EBITDAR has substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measures provide useful information to investors, the specific manner in which management uses these measures, and some of the limitations associated with the use of these measures, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Ensign’s website at http://www.ensigngroup.net.








Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
   
Exhibit No. Description
   
 
Press Release of the Company dated April 29, 2021
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
Dated: April 29, 2021
THE ENSIGN GROUP, INC. 
 By:  /s/ Suzanne D. Snapper   
  Suzanne D. Snapper  
  Chief Financial Officer and Executive Vice President (principal financial officer and accounting officer and duly authorized officer) 
 


EX-99.1 2 q12021pressrelease.htm EX-99.1 Document


ensigngrouplogoa02a01a341a.gif

The Ensign Group Reports First Quarter 2021 Results; Raises 2021 Earnings Guidance

Conference Call and Webcast scheduled for tomorrow, April 30, 2021 at 10:00 am PT
SAN JUAN CAPISTRANO, California – April 29, 2021 – The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, primarily in skilled nursing and senior living facilities, announced record operating results for the first quarter of 2021, reporting GAAP diluted earnings per share of $0.86 for the quarter ended March 31, 2021. Ensign also reported a record adjusted earnings per share(1) of $0.87 for the quarter.

Highlights Include:


GAAP diluted earnings per share for the quarter was $0.86, representing an increase of 17.8% over the prior year quarter. Adjusted diluted earnings per share for the quarter was $0.87, an increase of 13.0%(1) over the prior year quarter.

Consolidated GAAP revenues for the quarter were $627.3 million and adjusted revenues for the quarter were $626.8 million(1), both increased by 6.4% over the prior year quarter.

Same store and transitioning skilled revenue improved by 7.6% and 43.7%, respectively, over the prior year quarter with an increase in skilled mix days of 4.4% and 9.9%, respectively.

Same store occupancy increased by 0.4% and transitioning occupancy increased by 1.6%, both sequentially over the fourth quarter.

Same store and transitioning managed care daily revenue improved by 15.9% and 24.2%, respectively with increases in Managed Care daily census of 17.5% and 25.5%, respectively, sequentially over the fourth quarter.

Transitioning and skilled services(2) segment income increased to $88.9 million or 10.3% compared to prior year quarter and increased by $4.8 million or 5.7% sequentially over the fourth quarter.

Real estate(2) segment income was $8.8 million for the quarter, an increase of 39.5% from prior year quarter. FFO was $13.5 million for the quarter, an increase of 24.7% from prior year quarter.

GAAP net income was $49.2 million for the quarter, an increase of 20.5% from prior year quarter. Adjusted net income for the quarter $49.6 million for the quarter, an increase of 15.5%(1) over the prior year quarter.


(1) See "Reconciliation of GAAP to Non-GAAP Financial Information".
(2) Our Transitional and Skilled Services and Real Estate Segments are defined and outlined in Note 7 on Form 10-Q.




Operating Results

“We are very happy to report record results again this quarter. Thanks to early access to the vaccine, we have seen a significant reduction in the number of COVID-positive patients and staff in our operations throughout the first quarter and since with weekly resident and staff cases now in the single digits across our entire portfolio. As a result, our patients and caregivers have begun to enjoy an environment that, although certainly different in many ways, is starting to look and feel a lot more like pre-COVID times,” said Barry Port, Ensign’s Chief Executive Officer. “As they’ve shown so many times before, our locally-empowered leadership teams have yet again demonstrated the agility of our model as they have customized their strategies to meet the specific needs of the markets they serve. In doing so, our operations have separated themselves from a traditional nursing home care, remaining integral to the preservation of the healthcare continuum providing for complex medical needs. As they have done so, our operations have begun to see occupancies climb, particularly among our managed care patients. And now, as these operations emerge from the height of this crisis, they are poised to fill an even greater role than before as new standards for excellence in post-acute care,” he added.

Port noted that the Company saw a marked improvement in patient census, with a 3.4% and 18.6% increase in Medicaid and managed care average daily census, from the fourth quarter to first quarter for same store and transitioning portfolio, respectively. He also indicated that same store and transitioning managed care average daily census increased by 17.5% and 25.5%, respectively. “As we expected, as community spread of COVID has slowed, we have seen occupancies increase as the pent-up demand for healthcare services in our markets has continued to increase, while Medicare census has begun to trend toward pre-COVID levels. We expect the positive trend in occupancy to continue throughout the year, subject to some seasonality, as volumes in higher acute settings and managed care utilizations continue to increase. We look forward to continuing to work closely with our hospital and managed care partners in this new environment and to continue to demonstrate our ability to care for patients with the most complex medical needs,” he added.

Management increased the Company’s 2021 annual earnings guidance to $3.54 to $3.66 per diluted share, up from previous guidance of $3.44 to $3.56 per diluted share, and affirmed its previous annual revenue guidance of $2.62 billion to $2.69 billion. The midpoint of this 2021 earnings guidance represents an increase of approximately 15% over the Company’s 2020 results, which were 76% higher than 2019 results. Port noted that the increase comes from the strong results during the first quarter, positive trends in occupancy and the continuation of sequestration suspension, which provided some additional reimbursement that was not included in the original guidance. He added, “Our current health combined with our culture, proven local leadership strategy, healthy balance sheet, the enormous potential in our existing portfolio and the tremendous growth opportunities on the horizon, gives us confidence that we are well-positioned to not only rebound to our pre-COVID path but to accelerate our growth.”

The Company noted that the strong results in the quarter came from continued improvements in census and managed care skilled mix across the portfolio, company-wide cost saving initiatives, improved operational expense management, improved cash collections and the continuation of sequestration suspension and higher Medicaid funding in certain states. Commenting further on the quarter, Port said, “After one of the most challenging years in our history, our leaders are very excited to redirect the enormous energy spent on dealing with the pandemic towards continued improvement on the fundamentals that have made our operations so successful for so many years, including achieving high quality outcomes, driving occupancy, enhancing our clinical capabilities and managing costs. As we said last year, this pandemic arrived at our doorsteps at a time when our organization has never been stronger clinically and financially. As a result of being stretched to our limits in the face of this pandemic, we have learned many lessons and have become even stronger as our leaders and caregivers have made life-changing sacrifices on behalf of patients and their families. As we look out towards the near and long-term horizon as occupancies begin to climb towards pre-COVID levels and beyond, our existing portfolio truly has never had so much growth potential.”

Chief Financial Officer, Suzanne Snapper emphasized that the results for the quarter do not include any benefit related to CARES Act Provider Relief Funds and reminded investors that the Company continued to return all of the relief funds it received from the Government, which included approximately $9 million in provider grants in the first quarter of 2021 and approximately $2 million in April 2021. To date, all of the Provider Relief Funds, totaling over $152.9 million, have been returned to the government. She also indicated that in March the Company repaid all remaining Medicare advance payments from the Centers for Medicare and Medicaid Services (CMS) of approximately $102 million.

Ms. Snapper also reported that the company’s liquidity remains strong with approximately $155.5 million of cash on hand and $342.4 million of available capacity under its line-of-credit facility, which also has a built-in expansion option, both as of March 31, 2021. She also noted that the company also has 94 owned assets, 74 of which are unlevered and add additional liquidity.




Growth and Real Estate Highlights

The Company’s affiliates continued to acquire skilled nursing operations in some of its most mature markets. “Our ability to continue to grow in the midst of a pandemic is a true testament to our local team of clinical and operational leadership and their experience, planning and preparation. After a brief pause in our acquisition efforts during the early months of the pandemic, our teams have shown their commitment to one of the things that drives our organization, which is to consistently and methodically acquire, not only in good times, but even when it would be easier to shut down growth while waiting out the storm,” Chad Keetch, Ensign’s Chief Investment Officer, said. The following skilled nursing operations were acquired during the quarter and since:

Golden Hill Post Acute, a 99-bed skilled nursing facility located in San Diego, CA;

St. Catherine Healthcare, a 99-bed skilled nursing facility located in Fullerton, CA;

Camino Healthcare, a 99-bed skilled nursing facility located in Hawthorne, CA;

San Pedro Manor, a 150-bed skilled nursing facility located in San Antonio, TX;

Boulder Canyon Health and Rehabilitation, a 140-bed skilled nursing facility located in Boulder, Colorado;

Berthoud Care and Rehabilitation, a 76-bed skilled nursing facility located in Berthoud, Colorado; and

South Valley Post Acute Rehabilitation, a 106-bed skilled nursing facility located in Denver, Colorado.

These additions bring Ensign's growing portfolio to 235 healthcare operations, 22 of which also include senior living operations, across thirteen states. Ensign now owns 94 real estate assets, 64 of which it operates. “We are very excited about each of these hand-picked opportunities in some of our strongest markets and, because of the extra time we had to prepare given extra COVID protocols, we believe that each operation is poised to be a contributor to our results very soon,” Keetch said.

Keetch also noted that the pipeline for Ensign’s typical turnaround opportunities, in addition to some exciting strategic opportunities, remains strong. “We have plenty of capacity for what we still believe will be an attractive buyer’s market. We are actively looking to grow within our existing geographical footprint and will do so as we see significant advantages to adding strength in markets we know well, including some of our newer emerging markets as they continue to mature and prepare for growth,” he added.

Turning to the Company’s real estate portfolio, Keetch added, “We are pleased to announce that during the quarter we have made progress in our effort to select a structure that will allow us to better demonstrate the growing value in our owned real estate. Since our last call we have engaged advisors to help us determine the best path towards a structure inside of Ensign that highlights that value while not losing sight of our purpose-driven mission. We envision a structure that not only creates better visibility into the demonstrable value of our real estate but also will provide us with an efficient vehicle for future acquisitions of properties that could be operated by Ensign Affiliates or other third parties. We also seek a structure that will preserve the optionality that enables us to take advantage of private and public market conditions in order to maximize long term shareholder value. We are very excited about the new opportunities embedded in this chapter of our growth story and look forward, over the coming quarters, to updating you on our progress,” Keetch said.
The Company continues to provide additional disclosure on our new real estate segment, which is comprised of properties owned by us and leased to affiliated skilled nursing and senior living operations and 31 senior living operations that are leased to The Pennant Group, Inc. Keetch noted that each of these properties are subject to triple-net, long-term leases and generated rental revenue of $15.9 million for the quarter, of which $11.9 million was derived from Ensign affiliated operations. Also, for the first quarter of 2021 Ensign reported $13.5 million in FFO, which represents an increase of 24.7% over the prior year quarter of $10.8 million.

Also, during the quarter, the company paid a quarterly cash dividend of $0.0525 per share of Ensign common stock. Keetch noted that the company’s liquidity remains strong and that there are no current plans to suspend future dividends.

Conference Call

A live webcast will be held Friday, April 30, 2021 at 10:00 a.m. Pacific time (1:00 p.m. Eastern time) to discuss Ensign’s first quarter financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Ensign’s website at http://investor.ensigngroup.net. The webcast will be recorded, and will be available for replay via the website until 5:00 p.m. Pacific time on Friday, June 4, 2021.




About Ensign™

The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 235 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. As part of its investment strategy, the Company also acquire, lease and own healthcare real estate to service the post-acute care continuum through acquisition and investment opportunities in healthcare properties. Ensign’s new business venture operating subsidiaries also offer several other post-acute-related services, including mobile x-ray, non-emergency transportation services and other consulting services also across several states. Each of these operations is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the facilities, the Service Center or the captive insurance subsidiary are operated by the same entity. More information about Ensign is available at http://www.ensigngroup.net.

Management’s guidance is based on diluted weighted average common shares outstanding of approximately 57.8 million and a 25% tax rate. In addition, the guidance assumes, among other things, normalized health insurance costs, normal anticipated Medicare and Medicaid reimbursement rate increases, net of provider taxes, acquisitions closed in the first half of 2021 and recovery of the COVID-19 pandemic. It also excludes acquisition-related costs and amortization costs related to intangible assets acquired, share-based compensation and start-up losses.
A discussion of the company's use of non-GAAP financial measures is set forth below. A reconciliation of net income to EBITDA, adjusted EBITDAR, adjusted EBITDA, FFO for our real estate segment as well as a reconciliation of GAAP earnings per share, net income to adjusted net income and adjusted net earnings per share appear in the financial data portion of this release. More complete information is contained in the company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2021 which is filed with the SEC today and can be viewed on the company’s website at http://www.ensigngroup.net.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Additionally, our business and operations for 2021 continue to be impacted by the COVID-19 pandemic. Because of the unprecedented nature of the pandemic, we are unable to predict the full extent and duration of the financial impact of COVID-19 on our business, financial condition and results of operations. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company’s periodic filings with the Securities and Exchange Commission, including its Form 10-K and Form 10-Q, for a more complete discussion of the risks and other factors that could affect Ensign’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.






Contact Information
Investor/Media Relations, The Ensign Group, Inc., (949) 487-9500, ir@ensigngroup.net.
SOURCE: The Ensign Group, Inc.



THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME

Three Months Ended March 31,
(In thousands, except per share data)20212020
Revenue:
Service revenue$623,276 $585,951 
Rental revenue3,977 3,662 
Total revenue $627,253 $589,613 
Expense:
Cost of services482,186 454,521 
Rent—cost of services 33,456 32,330 
General and administrative expense34,273 32,249 
Depreciation and amortization13,659 13,720 
Total expenses563,574 532,820 
Income from operations63,679 56,793 
Other income (expense):
Interest expense(1,641)(3,665)
Interest and other income748 698 
Other expense, net(893)(2,967)
Income before provision for income taxes62,786 53,826 
Provision for income taxes12,949 12,625 
Net income 49,837 41,201 
Less: net income attributable to noncontrolling interests631 352 
Net income attributable to The Ensign Group, Inc.$49,206 $40,849 
Net income per share attributable to The Ensign Group, Inc.:
Basic $0.91 $0.76 
Diluted$0.86 $0.73 
Weighted average common shares outstanding:
Basic54,192 53,475 
Diluted56,891 55,796 




THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS


March 31, 2021December 31, 2020
(In thousands)
Assets
Current assets:
Cash and cash equivalents$155,527 $236,562 
Accounts receivable—less allowance for doubtful accounts of $11,090 and $8,718 at March 31, 2021 and December 31, 2020, respectively312,578 305,062 
Investments—current14,623 13,449 
Prepaid income taxes 1,224 
Prepaid expenses and other current assets30,588 26,659 
Total current assets513,316 582,956 
Property and equipment, net779,269 778,244 
Right-of-use assets 1,050,506 1,025,510 
Insurance subsidiary deposits and investments34,370 32,105 
Escrow deposits350 100 
Deferred tax assets32,424 32,424 
Restricted and other assets 41,422 33,155 
Intangible assets, net 2,828 2,899 
Goodwill 54,469 54,469 
Other indefinite-lived intangibles 3,546 3,716 
Total assets$2,512,500 $2,545,578 
Liabilities and equity
Current liabilities:
Accounts payable$53,942 $50,901 
Accrued wages and related liabilities203,420 236,614 
Lease liabilities—current 50,056 48,187 
Accrued self-insurance liabilities—current35,135 34,396 
Advance payment liabilities  102,023 
Other accrued liabilities 97,639 87,318 
Current maturities of long-term debt2,828 2,960 
Total current liabilities443,020 562,399 
Long-term debt—less current maturities111,859 112,544 
Long-term lease liabilities—less current portion 973,679 950,320 
Accrued self-insurance liabilities—less current portion66,742 62,402 
Other long-term liabilities41,620 39,686 
Total equity875,580 818,227 
Total liabilities and equity$2,512,500 $2,545,578 



THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:

Three Months Ended March 31,
20212020
(In thousands)
Net cash provided by/(used in):
Operating activities$34,294 $27,123 
Investing activities(12,212)(15,542)
Financing activities(103,117)(7,539)
Net (decrease)/increase in cash and cash equivalents(81,035)4,042 
Cash and cash equivalents beginning of period236,562 59,175 
Cash and cash equivalents at end of period$155,527 $63,217 




THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands, except per share data)

RECONCILIATION OF GAAP TO NON-GAAP NET INCOME

The following table reconciles net income to Non-GAAP net income for the periods presented:

Three Months Ended March 31,
20212020
Net income $49,206 $40,849 
Non-GAAP adjustments
Stock-based compensation expense(a)4,054 3,235 
Results related to operations not at full capacity(b)657 416 
Acquisition related costs(c)36 50 
Depreciation and amortization - patient base(d)12 213 
Cost of services - gain on sale of assets(540)— 
Provision for income taxes on Non-GAAP adjustments(e)(3,801)(1,809)
Non-GAAP income $49,624 $42,954 
Average number of diluted shares outstanding56,891 55,796 
Diluted Earnings Per Share
Net income$0.86 $0.73 
Adjusted Diluted Earnings Per Share
Net Income$0.87 $0.77 
Footnotes:
(a) Represents stock-based compensation expense incurred.
Three Months Ended March 31,
20212020
Cost of services$2,500 $2,111 
General and administrative1,554 1,124 
Total Non-GAAP adjustment$4,054 $3,235 
(b) Represents results to operations not at full capacity
Three Months Ended March 31,
20212020
Revenue$(456)$(729)
Cost of services1,040 1,071 
Rent38 22 
Depreciation and amortization35 52 
Total Non-GAAP adjustment$657 $416 
(c) Represents costs incurred to acquire an operation which are not capitalizable.
(d) Included in depreciation and amortization are expenses related to patient base intangible assets at newly acquired skilled nursing and senior living facilities.
(e) Represents an adjustment to the provision for income tax to our historical year to date effective tax rate of 25.0% for the three months ended March 31, 2021 and 2020.




THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands)

The table below reconciles net income to EBITDA, Adjusted EBITDA and Adjusted EBITDAR for the periods presented:

Three Months Ended March 31,
20212020
Consolidated Statements of Income Data:
Net income attributable to The Ensign Group, Inc.$49,837 $41,201 
Less: net income attributable to noncontrolling interests631 352 
Add: Interest expense, net893 2,967 
Provision for income taxes12,949 12,625 
Depreciation and amortization13,659 13,720 
EBITDA$76,707 $70,161 
Adjustments to EBITDA:
Stock-based compensation expense4,054 3,235 
Results related to operations not at full capacity(a)584 342 
Gain on sale on assets(540)— 
Acquisition related costs(b)36 50 
Rent related to items above38 22 
Adjusted EBITDA$80,879 $73,810 
Rent—cost of services33,456 32,330 
Less: rent related to items above(38)(22)
Adjusted rent 33,418 32,308 
Adjusted EBITDAR $114,297 
(a)    Represents results at closed operations and operations not at full capacity.
(b)    Costs incurred to acquire operations which are not capitalizable.


THE ENSIGN GROUP, INC.
UNAUDITED SELECT PERFORMANCE INDICATORS

The following tables summarize our selected performance indicators for our transitional and skilled services segment along with other statistics, for each of the dates or periods indicated:
Three Months Ended March 31,
 20212020Change% Change
Total Facility Results:(Dollars in thousands)  
Transitional and skilled revenue(4)
$601,036 $558,304 $42,732 7.7 %
Number of facilities at period end200 194 3.1 %
Number of campuses at period end*23 22 4.5 %
Actual patient days(4)
1,509,600 1,643,390 (133,790)(8.1)%
Occupancy percentage — Operational beds71.1 %79.4 %(8.3)%
Skilled mix by nursing days34.4 %29.3 %5.1 %
Skilled mix by nursing revenue55.6 %50.1 %5.5 %




Three Months Ended March 31,
 20212020Change% Change
Same Facility Results(1):(Dollars in thousands)  
Transitional and skilled revenue(4)
$491,790 $476,896 $14,894 3.1 %
Number of facilities at period end165 165 — — %
Number of campuses at period end*15 15 — — %
Actual patient days(4)
1,219,693 1,371,803 (152,110)(11.1)%
Occupancy percentage — Operational beds72.2 %80.4 %(8.2)%
Skilled mix by nursing days35.4 %31.0 %4.4 %
Skilled mix by nursing revenue56.6 %52.1 %4.5 %

Three Months Ended March 31,
20212020Change% Change
Transitioning Facility Results(2):(Dollars in thousands)  
Transitional and skilled revenue(4)
$89,025 $79,027 $9,998 12.7 %
Number of facilities at period end26 26 — — %
Number of campuses at period end*7 — — %
Actual patient days(4)
235,668 263,341 (27,673)(10.5)%
Occupancy percentage — Operational beds66.9 %74.7 %(7.8)%
Skilled mix by nursing days30.6 %20.7 %9.9 %
Skilled mix by nursing revenue51.2 %38.7 %12.5 %

Three Months Ended March 31,
20212020Change% Change
Recently Acquired Facility Results(3):(Dollars in thousands)  
Transitional and skilled revenue(4)
$20,221 $2,381 $17,840 NM
Number of facilities at period end9 NM
Number of campuses at period end*1 — NM
Actual patient days(4)
54,239 8,246 45,993 NM
Occupancy percentage — Operational beds66.8 %73.6 %NM
Skilled mix by nursing days28.1 %18.1 %NM
Skilled mix by nursing revenue49.5 %31.7 %NM
* Campus represents a facility that offers both skilled nursing and senior living services. Revenue and expenses related to skilled nursing and senior living services have been allocated and recorded in the respective operating segment.
(1)Same Facility results represent all facilities purchased prior to January 1, 2018.
(2)Transitioning Facility results represent all facilities purchased from January 1, 2018 to December 31, 2019.
(3)Recently Acquired Facility (Acquisitions) results represent all facilities purchased on or subsequent to January 1, 2020.
(4)The first quarter of 2021 included 90 days compared to 91 days for the same period in 2020 as a result of the leap year.





THE ENSIGN GROUP, INC.
SKILLED NURSING AVERAGE DAILY REVENUE RATES AND
PERCENT OF SKILLED NURSING REVENUE AND DAYS BY PAYOR
(Unaudited)

The following table reflects the change in skilled nursing average daily revenue rates by payor source, excluding services that are not covered by the daily rate(1):
Three Months Ended March 31,
 Same FacilityTransitioningAcquisitionsTotal
 20212020202120202021202020212020
Skilled Nursing Average Daily
Revenue Rates:
Medicare$691.83 $663.60 $678.43 $628.33 $737.01 $508.35 $691.34 $657.78 
Managed care505.34 477.01 484.69 438.87 365.48 416.96 500.13 472.74 
Other skilled546.42 523.47 400.72 323.86 512.79 — 533.43 513.89 
Total skilled revenue595.16 560.95 576.89 531.21 604.56 485.19 592.90 557.35 
Medicaid251.41 231.40 241.67 219.18 240.72 232.31 249.38 229.23 
Private and other payors239.48 233.91 241.99 218.82 243.88 228.44 240.06 230.95 
Total skilled nursing revenue$371.89 $333.89 $344.15 $283.62 $343.36 $277.07 $366.53 $325.54 
(1) These rates exclude additional FMAP we recognized and include sequestration reversal of 2%.

The following tables set forth our percentage of skilled nursing patient revenue and days by payor source for the three months ended March 31, 2021 and 2020:
 Three Months Ended March 31,
 Same FacilityTransitioningAcquisitionsTotal
 20212020202120202021202020212020
Percentage of Skilled
Nursing Revenue:
Medicare29.4 %25.2 %30.9 %24.1 %33.2 %24.8 %29.7 %25.0 %
Managed care19.0 18.9 17.3 13.0 6.4 6.9 18.3 18.0 
Other skilled8.2 8.0 3.0 1.6 9.9 — 7.6 7.1 
Skilled mix56.6 52.1 51.2 38.7 49.5 31.7 55.6 50.1 
Private and other payors5.9 7.7 7.0 10.6 6.9 21.1 6.1 8.1 
Medicaid37.5 40.2 41.8 50.7 43.6 47.2 38.3 41.8 
Total skilled nursing100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %

 Three Months Ended March 31,
 Same FacilityTransitioningAcquisitionsTotal
 20212020202120202021202020212020
Percentage of Skilled
Nursing Days:
Medicare15.8 %12.7 %15.7 %10.9 %15.5 %13.5 %15.8 %12.4 %
Managed care14.0 13.2 12.3 8.4 6.0 4.6 13.4 12.4 
Other skilled5.6 5.1 2.6 1.4 6.6 — 5.2 4.5 
Skilled mix35.4 31.0 30.6 20.7 28.1 18.1 34.4 29.3 
Private and other payors9.1 11.0 9.9 13.8 9.7 25.6 9.3 11.5 
Medicaid55.5 58.0 59.5 65.5 62.2 56.3 56.3 59.2 
Total skilled nursing100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %




THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION BY SEGMENT
(In thousands)

Transitional and Skilled Services

The table below reconciles net income to EBITDA and Adjusted EBITDA for the transitional and skilled services reportable segment for the periods presented:

Three Months Ended March 31,
20212020
Statements of Income Data:
Segment income(a)$88,931 $80,591 
Depreciation and amortization7,475 7,148 
EBITDA96,406 87,739 
Adjustments to EBITDA:
Stock-based compensation expense2,411 2,000 
Adjusted EBITDA$98,817 $89,739 
(a)    Segment income reflects profits or loss from operations before provision for income taxes, excluding gain or loss from sale of real estate, insurance recoveries and impairment charges from operations. General and administrative expenses are not allocated to any segment for purposes of determining segment profit or loss.


Real Estate
The following table sets forth details of operating results for our revenue and earnings, and their respective components, by our real estate segment for the periods indicated:
Three Months Ended March 31,
20212020
Rental revenue generated from third-party tenants$3,977 $3,662 
Rental revenue generated from Ensign affiliated operations11,902 11,282 
Total rental revenue15,879 14,944 
Segment income(a)8,821 6,325 
Depreciation and amortization4,693 4,515 
FFO(b)$13,514 $10,840 
(a) Segment income reflects profits or loss from operations before provision for income taxes, excluding gain or loss from sale of real estate, insurance recoveries and impairment charges from operations. General and administrative expenses are not allocated to any segment for purposes of determining segment profit or loss.
(b) FFO, in accordance with the definition used by the National Association of Real Estate Investment Trusts, means net income attributable to common stockholders, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairment of depreciable real estate assets and including depreciation and amortization related to real estate to earnings.




THE ENSIGN GROUP, INC.
UNAUDITED REVENUE BY PAYOR SOURCE


The following table sets forth our service revenue by payor source and as a percentage of total service revenue for the periods indicated:

 Three Months Ended March 31,
20212020
Revenue% of RevenueRevenue% of Revenue
Medicaid(1)
$231,358 37.1 %$224,195 38.3 %
Medicare190,303 30.5 155,584 26.6 
Medicaid — skilled39,993 6.5 36,009 6.1 
Total Medicaid and Medicare461,654 74.1 415,788 71.0 
Managed care108,345 17.4 102,029 17.4 
Private and other(2)
53,277 8.5 68,134 11.6 
Service revenue$623,276 100.0 %$585,951 100.0 %
(1) Medicaid payor includes revenue for senior living operations and revenue related to FMAP for the three months ended March 31, 2021 and 2020.
(2) Private and other payors also includes revenue from all payors generated in our other ancillary operations for the three months ended March 31, 2021 and 2020.


Discussion of Non-GAAP Financial Measures

EBITDA consists of net income before (a) interest expense, net, (b) provisions for income taxes and (c) depreciation and amortization. Adjusted EBITDA consists of net income before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) stock-based compensation expense; (e) results of operations not at full capacity, excluding depreciation, interest and income taxes, (f) acquisition related costs and (g) gain on sale of assets. Adjusted EBITDAR consists of net income before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) stock-based compensation expense; (f) results of operations not at full capacity, excluding rent, depreciation, interest and income taxes, (g) acquisition related costs and (h) gain on sale of assets. Funds from Operations (FFO) for our real estate segment consists of segment income, excluding gains or losses from sales of real estate, insurance recoveries related to real estate and impairment of depreciable real estate assets and including depreciation and amortization related to real estate to earnings. The company believes that the presentation of EBITDA, adjusted EBITDA, FFO, adjusted net income and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. Adjusted EBITDAR is a financial valuation measure that is not specified in GAAP. This measure is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense. The company believes disclosure of adjusted net income, adjusted net income per share, FFO, EBITDA, adjusted EBITDA and adjusted EBITDAR has substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measures provide useful information to investors, the specific manner in which management uses these measures, and some of the limitations associated with the use of these measures, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Ensign’s website at http://www.ensigngroup.net.



EX-101.SCH 3 ensg-20210429.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Document link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 ensg-20210429_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 ensg-20210429_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 ensg-20210429_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Type Document Type Entity Address, Postal Zip Code Entity Address, Postal Zip Code Local Phone Number Local Phone Number Amendment Flag Amendment Flag Written Communications Written Communications City Area Code City Area Code Title of 12(b) Security Title of 12(b) Security Entity Address, State or Province Entity Address, State or Province Security Exchange Name Security Exchange Name Soliciting Material Soliciting Material Document Period End Date Document Period End Date Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Cover page. Cover [Abstract] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Emerging Growth Company Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Trading Symbol Trading Symbol EX-101.PRE 7 ensg-20210429_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 ensigngrouplogoa02a01a341a.gif begin 644 ensigngrouplogoa02a01a341a.gif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end XML 9 ensg-20210429_htm.xml IDEA: XBRL DOCUMENT 0001125376 2021-04-29 2021-04-29 0001125376 false 8-K 2021-04-29 Ensign Group, Inc DE 001-33757 33-0861263 29222 Rancho Viejo Road, Suite 127, San Juan Capistrano, CA 92675 949 487-9500 false false false false Common Stock, par value $0.001 per share ENSG NASDAQ false XML 10 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Cover Document
Apr. 29, 2021
Cover [Abstract]  
Document Type 8-K
Document Period End Date Apr. 29, 2021
Entity Registrant Name Ensign Group, Inc
Entity Incorporation, State or Country Code DE
Entity File Number 001-33757
Entity Tax Identification Number 33-0861263
Entity Address, Address Line One 29222 Rancho Viejo Road, Suite 127,
Entity Address, City or Town San Juan Capistrano,
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92675
City Area Code 949
Local Phone Number 487-9500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol ENSG
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001125376
Amendment Flag false
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 96 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Document Sheet http://www.ensigngroup.net/role/CoverDocument Cover Document Cover 1 false false All Reports Book All Reports ensg-20210429.htm ensg-20210429.xsd ensg-20210429_cal.xml ensg-20210429_def.xml ensg-20210429_lab.xml ensg-20210429_pre.xml q12021pressrelease.htm http://xbrl.sec.gov/dei/2020-01-31 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ensg-20210429.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "ensg-20210429_cal.xml" ] }, "definitionLink": { "local": [ "ensg-20210429_def.xml" ] }, "inline": { "local": [ "ensg-20210429.htm" ] }, "labelLink": { "local": [ "ensg-20210429_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "ensg-20210429_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "ensg-20210429.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ensg", "nsuri": "http://www.ensigngroup.net/20210429", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ensg-20210429.htm", "contextRef": "id60ccad9f00842ae8df3293002ee1322_D20210429-20210429", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Document", "role": "http://www.ensigngroup.net/role/CoverDocument", "shortName": "Cover Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ensg-20210429.htm", "contextRef": "id60ccad9f00842ae8df3293002ee1322_D20210429-20210429", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 17 0001125376-21-000078-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001125376-21-000078-xbrl.zip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